15 March 2024 in Trends in Biotechnology
In bone tissue engineering (TE) and regeneration, miniaturized, (sub)millimeter-sized bone models have become a popular trend since they bring about physiological biomimicry, precise orchestration of concurrent stimuli, and compatibility with high-throughput setups and high-content imaging. They also allow efficient use of cells, reagents, materials, and energy. In this review, we describe the state of the art of miniaturized in vitro bone models, or 'mini-bones', describing these models based on their characteristics of (multi)cellularity and engineered extracellular matrix (ECM), and elaborating on miniaturization approaches and fabrication techniques. We analyze the performance of 'mini-bone' models according to their applications for studying basic bone biology or as regeneration models, disease models, and screening platforms, and provide an outlook on future trends, challenges, and opportunities.
14 November 2025 in European Journal of Trauma and Emergency Surgery
Introduction: The Induced Membrane Technique (IMT) combined with autologous bone grafting has proven effective in achieving union in many cases of non-healing bone defects. However, this treatment strategy remainschallenging in very large defects (≥ 10 cm). Although the addition of a 3D-printed scaffold could enhance osteoconductivity and retention of cancellous bone, cells, and bioactive materials in the defect, the long-term outcomes of this innovative approach are not yet known. We therefore reviewed all patients with a very large posttraumatic segmental defect of a long bone treated with the IMT using a 3D-printed scaffold, cancellous bone, cells, and bioactive materials. Methods: From 2018 to 2024, all consecutive patients with a large segmental defect who received a 3D printed scaffold were identified. All patients were treated with the two-stage IMT procedure. The defects were filled in the second stage procedure with a 3D printed scaffold made from poly-ε-caprolactone and Tricalcium Phosphate (PCL/TCP), autologous bone graft (bone marrow aspirate concentrate and RIA-autograft), and biomaterials(P-15 +/- bioactive glass). In the event of complications, samples from the defect site with the PCL/TCP scaffold were collected for analysis using scanning electron microscopy and histology. Results: A total of ten patients were treated for a segmental bone defect median of 10.5 cm (IQR 3.25) of the femur ( n = 3) or tibia ( n = 7). Follow-up of the patients ranges between one and four years. The median age of the patients is 46 (range 23–62). Complications occurred in seven patients (one femur, six tibia). All patients with complications required additional surgeries. One patient had a local osteomyelitis infection at the defect site with complete integration of the scaffold into the proximal and distal tibia; one required negative pressure wound therapy for a soft tissue infection; and five required a revision of the first stage procedure due to surgical site infection ( n = 3) or failure of the fracture fixation material ( n = 2). Remarkably, scanning electron microscopy and histology showed limited formation and incorporation of newly formed bone into the scaffold. After revision surgery, all patients are currently improving, and no amputations have been performed so far. Conclusion: Reconstructive treatment of large bone defects remains challenging. The short-term follow-up of this treatment strategy showed promising results with progress in clinical and radiological follow-up. However, in this small cohort a lack of bone growth at the defect site was found in some of the cases that were clinically performing well. The use of PCL/TCP scaffolds remains a valuable treatment strategy in very large bone defects for retention and extension of the autologous bone and cells, though improvements in fixation, composition or structural properties could enhance their feasibility.
1 April 2024 in ACS Applied Materials & Interfaces
Three-dimensional (3D) cell assemblies, such as multicellular spheroids, can be powerful biological tools to closely mimic the complexity of cell–cell and cell–matrix interactions in a native-like microenvironment. However, potential applications of large spheroids are limited by the insufficient diffusion of oxygen and nutrients through the spheroids and, thus, result in the formation of a necrotic core. To overcome this drawback, we present a new strategy based on nanoparticle-coated microparticles. In this study, microparticles function as synthetic centers to regulate the diffusion of small molecules, such as oxygen and nutrients, within human mesenchymal stem cell (hMSC) spheroids. The nanoparticle coating on the microparticle surface acts as a nutrient reservoir to release glucose locally within the spheroids. We first coated the surface of the poly(lactic-co-glycolic acid) (PLGA) microparticles with mesoporous silica nanoparticles (MSNs) based on electrostatic interactions and then formed cell-nanofunctionalized microparticle spheroids. Next, we investigated the stability of the MSN coating on the microparticles’ surface during 14 days of incubation in cell culture medium at 37 °C. Then, we evaluated the influence of MSN-coated PLGA microparticles on spheroid aggregation and cell viability. Our results showed the formation of homogeneous spheroids with good cell viability. As a proof of concept, fluorescently labeled glucose (2-NBD glucose) was loaded into the MSNs at different concentrations, and the release behavior was monitored. For cell culture studies, glucose was loaded into the MSNs coated onto the PLGA microparticles to sustain local nutrient release within the hMSC spheroids. In vitro results demonstrated that the local delivery of glucose from MSNs enhanced the cell viability in spheroids during a short-term hypoxic culture. Taken together, the newly developed nanofunctionalized microparticle-based delivery system may offer a versatile platform for local delivery of small molecules within 3D cellular assemblies and, thus, improve cell viability in spheroids.
17 September 2025 in ACS Biomaterials Science & Engineering
AGAlexander P. M. Guttenplan
Alexander P. M. Guttenplan
+5
Cellular spheroids are considered a popular option for modeling healthy and diseased tissues in vitro and as injectable therapies. The formation and culture of spheroids can make use of different three-dimensional (3D) culture platforms, but the spheroids’ analysis often has to rely on endpoint assays. In this study, we propose a microfluidic bioreactor to culture and nondestructively monitor human mesenchymal stem cell (hMSC) spheroids over time using non-Faradaic electr(ochem)ical impedance spectroscopy (EIS). For this, an array of porous microwells thermoformed from ion track-etched thin films and a pair of sensing electrodes from transparent indium tin oxide are integrated into the flow and culture chamber of the bioreactor. To measure the spheroid’s electrical properties, the electrodes are connected to a frequency response analyzer (FRA), with a multiplexer in between to enable the operation of more than one bioreactor at the FRA at the same time. We find differences between the complex resistance/impedance and/or capacitance data of a reference condition without cells, a two-dimensional (2D) hMSC culture, hMSC spheroids, and hybrid spheroids aggregated from hMSCs and titanium or hydroxyapatite microparticles. We also found differences between different culture durations. These results suggest that our device can sense the presence and spatial arrangement of cells and micro(sized) biomaterials as a function of time.
11 June 2026 in SSRN Electronic Journal
Tissue engineering strategies focus on developing and unravelling cell–biomaterial interactions. By tuning the biophysical and biochemical properties of biomaterials, it is possible to adjust how cells respond to an artificial 3D microenvironment towards a specific outcome. Despite several proven improvements on recreating these artificial microenvironments, imparted biophysical and biochemical modifications lack the diversity of cell–extracellular matrix interactions found in vivo. Here, we describe a custom-made microwell culture device that allows high-throughput screening (HTS) of human mesenchymal stem/stromal cells (hMSCs) in a 3D alginate hydrogel, modified through click thiol-ene chemistry with all possible combinations of five relevant peptide motifs mimicking the bone marrow niche proteins. This culture system, which is compatible with automated confocal image acquisition and Cell Profiler analysis, shows that hMSCs modulate differently their proliferation and cell shape in response to the multiple combinations of adhesion peptide motifs. Additionally, we found that hMSC proliferation at day 1 positively correlated with cell spreading, supporting previous observations that increased cell spreading is associated with enhanced proliferative activity. In conclusion, the microwell HTS can be used to screen 3D hydrogel culture systems and microenvironments to monitor and understand the best combination of peptide adhesive motifs for targeted applications.